Lin Jiunn

Lin Jiunn is a small, for-profit sole proprietorship located in Ambler, Pennsylvania, registered in the System for Award Management (SAM.gov) since June 2012. The company appears to specialize in providing expert consulting services in the field of drug metabolism and pharmacokinetics (DMPK), with a primary focus on supporting biomedical research initiatives within the National Institutes of Health (NIH) ecosystem.

Lin Jiunn has been awarded multiple federal contract purchase orders from key NIH institutes, specifically the National Institute on Drug Abuse (NIDA) and the National Institute of Neurological Disorders and Stroke (NINDS). The contracts, ranging from $10,000 to $604,500, are for subject matter expert consultant services in drug metabolism pharmacokinetics, supporting programs such as the NIH Blueprint Neurotherapeutics Network, HEAL, and Biologics programs. These contracts have varying performance periods between 2022 and 2026, with most recent awards in 2025. While some contracts were set aside for small businesses (such as the NIDA contract), others were not designated with a specific set-aside. The consulting work appears to be centered on providing specialized scientific expertise to support advanced neurological and drug research initiatives, with contracts typically structured as purchase orders based on labor hours and expert consultation.